Reflections on an excellent EBMT 2018
The 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, proved to be an exciting congress with >5,000 delegates in attendance - the highest attenda...
Author: VJHemOnc
Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Endothelial dysfunction in transplant: defibrotide for VOD
Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks abou...
Author: VJHemOnc
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Highlights from the successful 2018 EBMT annual meeting
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital, Paris, France, discusses th...
Author: VJHemOnc
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Working with smaller research companies
Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH), Stphane de Botton, MD, PhD of the Gustave Roussy Institute, ...
Author: VJHemOnc
Added: 12/06/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 6, 2017 Category: Cancer & Oncology Source Type: podcasts
Transferring lessons learnt from treating ALL to AML
Reflecting upon past research is key to the development of new treatments. In this interview at the International Conference of Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School o...
Author: VJHemOnc
Added: 12/05/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 5, 2017 Category: Cancer & Oncology Source Type: podcasts
& quot;AML immunotherapy: pre-clinical data to look forward to at ASH 2017 & quot;
It is still early days for immunotherapeutic strategies. Speaking from the International Conference on Acute Myeloid Leukemia 2017, Estoril, Portugal by the European School of Hematology (ESH), Marion...
Author: VJHemOnc
Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts
Selecting AML patients for intensive treatment
Many variables are involved in selecting the type of treatment that a patient can receive. Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European...
Author: VJHemOnc
Added: 11/28/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2017 Category: Cancer & Oncology Source Type: podcasts
Reassuring patients with AML
Compassion and understanding are two key components within medical care. At the International Conference of Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH)...
Author: VJHemOnc
Added: 11/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 27, 2017 Category: Cancer & Oncology Source Type: podcasts
The future of leukemia treatment in the elderly
An advanced age can limit treatment options when tackling leukemia. Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Hematology (...
Author: VJHemOnc
Added: 11/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Bispecific agents: the future of AML and MDS treatment?
It is crucial that drug toxicity is kept as low as possible to improve the quality of life of patients. Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by...
Author: VJHemOnc
Added: 11/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2017 Category: Cancer & Oncology Source Type: podcasts
Highly targeted medication for AML
There have been large strides in the treatment of leukemia; however, current methods lack specificity. Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by ...
Author: VJHemOnc
Added: 11/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Genomic Profiling For Breast Cancer Patients
Dr Fatima Cardoso, Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, speaks from ESMO 2017.
Author: patientpower
Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts
The Advanced Breast Cancer Global Alliance
Dr Fatima Cardoso, Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, speaks from ESMO 2017.
Author: patientpower
Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts
ESMO 17: Advances For Metastatic Breast Cancer Patients
Dr Fatima Cardoso, Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, speaks from ESMO 2017.
Author: patientpower
Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts
What Is The Role Of Immunotherapy In The Future Of Breast Cancer?
Dr Fatima Cardoso, Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, speaks from ESMO 2017.
Author: patientpower
Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts
